One Year After Japan Paves Way, Follow-on Biologics Start Blossoming
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare has seen an influx of companies interested in bringing products to Japan since releasing official guidelines for biosimilars last March